Does TOFACITINIB Cause Onychomycosis? 601 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 601 reports of Onychomycosis have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.4% of all adverse event reports for TOFACITINIB.
601
Reports of Onychomycosis with TOFACITINIB
0.4%
of all TOFACITINIB reports
288
Deaths
456
Hospitalizations
How Dangerous Is Onychomycosis From TOFACITINIB?
Of the 601 reports, 288 (47.9%) resulted in death, 456 (75.9%) required hospitalization, and 282 (46.9%) were considered life-threatening.
Is Onychomycosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 601 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Onychomycosis?
ADALIMUMAB (791)
METHOTREXATE (742)
RITUXIMAB (708)
TOCILIZUMAB (706)
ETANERCEPT (683)
INFLIXIMAB (630)
CERTOLIZUMAB PEGOL (629)
GOLIMUMAB (625)
ABATACEPT (615)
HYDROXYCHLOROQUINE (590)
Which TOFACITINIB Alternatives Have Lower Onychomycosis Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN